Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $829000.0.

  • Amicus Therapeutics' Interest & Investment Income fell 2331.17% to $829000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 3111.97%. This contributed to the annual value of $5.4 million for FY2024, which is 2360.84% down from last year.
  • Latest data reveals that Amicus Therapeutics reported Interest & Investment Income of $829000.0 as of Q3 2025, which was down 2331.17% from $843000.0 recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Interest & Investment Income high stood at $2.2 million for Q1 2023, and its period low was $50000.0 during Q2 2021.
  • Moreover, its 5-year median value for Interest & Investment Income was $843000.0 (2025), whereas its average is $973789.5.
  • In the last 5 years, Amicus Therapeutics' Interest & Investment Income tumbled by 9421.97% in 2021 and then soared by 155338.35% in 2023.
  • Amicus Therapeutics' Interest & Investment Income (Quarter) stood at $186000.0 in 2021, then soared by 960.22% to $2.0 million in 2022, then fell by 15.26% to $1.7 million in 2023, then decreased by 15.26% to $1.4 million in 2024, then plummeted by 41.45% to $829000.0 in 2025.
  • Its Interest & Investment Income stands at $829000.0 for Q3 2025, versus $843000.0 for Q2 2025 and $812000.0 for Q1 2025.